SANUWAVE Health Projects Q1 Revenue of $9.6M-$9.7M
Summary
SANUWAVE Health, Inc. has provided first-quarter revenue guidance, expecting to report between $9.6 million and $9.7 million. This forward-looking statement offers investors an early indication of the company's performance for the current fiscal year. This guidance follows the company's recent 10-K filing on March 26, which detailed a restatement of prior financials and a 35% revenue increase for the previous fiscal year. For a company of SANUWAVE's size, this specific revenue range is a material update that will influence investor expectations and valuation models. Traders will be watching for the official Q1 earnings release to confirm these figures and gain further insight into profitability and operational trends.
At the time of this announcement, SNWV was trading at $18.02 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $154.9M. The 52-week trading range was $16.27 to $46.59. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.